Table 6.
Prescription of anticoagulants according to the CHADS2 and CHA2DS2-VASc score in the first six months after the diagnosis of atrial fibrillation (n = 1830)
| CHADS2 score | |||
| 0 (n = 285, 15.5 %) | 1 (n = 654, 36 %) | ≥2 (n = 891, 48.5 %) | |
| Anticoagulants, n (%) | 146 (51) | 306 (47) | 443 (50) |
| No anticoagulants, n (%) | 139 (49) | 348 (53) | 448 (50) |
| CHA2DS2-VASc score | |||
| 0 (n = 19, 1 %) | 1 (n = 157, 9 %) | ≥2 (n = 1654, 90 %) | |
| Anticoagulants, n (%) | 11 (58) | 81 (52) | 803 (49) |
| No anticoagulants, n (%) | 8 (42) | 76 (48) | 851 (51) |